Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest ankylosing spondylitis Stories

2009-04-13 15:15:00

Canadian Approval Is World's First Regulatory Approval for SIMPONI HORSHAM, Pa. and KENILWORTH, N.J., April 13 /PRNewswire-FirstCall/ Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) today announced that Health Canada has granted approval of SIMPONI (TM) (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS)....

2009-04-10 03:43:00

TAIPEI, Taiwan, April 10 /PRNewswire/ -- Rheumatoid arthritis (RA) is a systemic disease or an autoimmune disorder in which the body's defense system attacks the joints through the thin layer of cells called the synovium that lines and lubricates the joints. The most visible symptoms of RA are swollen joints and crippling stiffness, particularly of the hands and feet. It can cause fatigue, fever, loss of appetite and also impedes mobility and quality of life. (Logo:...

2008-11-12 12:00:07

HORSHAM, Pa., Nov. 12 /PRNewswire/ -- Centocor, Inc. announced today the launch of MEDVERSATION(TM) (http://www.medversation.com/), an extensive web-based resource designed to facilitate more-informed conversations between U.S. physicians and their patients about the efficacy and safety of REMICADE(R) (infliximab). This interactive web application, in development for the past three years and the first in its therapeutic class, provides physicians general information about the progression...

2008-10-27 09:00:12

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- More than half of patients receiving every four week subcutaneous injections of golimumab (CNTO 148) 50 mg and 100 mg, an investigational therapy, experienced sustained improvements in the joint and skin symptoms of active psoriatic arthritis through six months with results sustained through one year. Golimumab-treated patients also experienced improvements in health-related quality of life (HRQOL) in the placebo-controlled portion of the study...

2008-10-10 15:00:09

DEAR DR. DONOHUE: My brother was recently told he has ankylosing spondylitis. He's in his early 50s and has posture like Ed Sullivan, who had the same disease. He gives himself a shot of Humira. He has a lot of pain. Is ankylosing spondylitis inherited? How likely is it that some of the rest of us nine kids could inherit it? - K.H. ANSWER: Ankylosing (AN-kuh-LOW-sing) spondylitis (SPAWN-duh-LITE- is) is arthritis that affects primarily the backbones, the vertebrae. It often begins as a dull...

2008-06-30 12:03:15

Centocor has submitted a biologics license application to the FDA requesting the approval of golimumab as a monthly subcutaneous treatment for adults with active forms of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Golimumab, Centocor's next-generation human anti-TNF-alpha monoclonal antibody, is being studied as an every four week subcutaneous injection and is also being studied as an intravenous (IV) infusion therapy. Jerome Boscia, senior vice president,...

2005-11-11 14:52:34

NEW YORK (Reuters Health) - Exercise programs are beneficial for people with a type of arthritis affecting the spine -- ankylosing spondylitis (AS) -- Norwegian researchers report, although it is not clear which type of protocol is best. Dr. Hanne Dagfinrud of the University of Oslo and colleagues reviewed of 43 studies involving exercise and AS and eventually scrutinized data on a total of 561 patients in six trials. The results are published in the Journal of Rheumatology. In the...

2005-06-15 18:25:00

When kids or teens experience aching joints and stiffness it may be more than growing pains. It may be arthritis of the spine and other joints (ankylosing spondylitis), which researchers report can often go undiagnosed for years and years, leading to serious problems in adulthood. The findings, generated from a national life impact study and reported in the June 15 issue of Arthritis Care and Research, highlight a need for increased awareness and earlier treatment of the disease. "Many...

2005-06-02 01:50:00

A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine. Commonly striking in young adulthood, before age 35, AS causes inflammation, pain, and stiffness in the spinal joints--the vertebrae--and the sacroiliac joint, where the spinal column meets the pelvis. In advanced cases, this disease can result in deforming, crippling spinal fusion and organ damage. According to expert estimates, AS afflicts at least half a million...